HGP – Clinipace Worldwide co-founders named E&Y Entrepreneur of the Year finalists
Thursday, May 7, 2015 Clinipace Worldwide, a global digital CRO, has announced Jeff Williams, CEO and co-founder, and Chris Porter, president and co-founder, have been named one of three finalists in the Health Care & Life Sciences category of the Ernst & Young Entrepreneur Of The Year 2015 Southeast Program, which includes Alabama, Georgia, North Carolina, South Carolina and Tennessee. The awards program recognizes entrepreneurs who demonstrate excellence and extraordinary success in areas such as innovation, financial performance and personal commitment to their businesses and communities.
Williams and Porter founded Clinipace in 2003 as a software company and have since built the first global full-service digital CRO. From 2012 to 2014, the company experienced a growth rate of 348% and added more than 450 jobs. In addition to its strong organic sales growth, Clinipace has had six acquisitions in as many years, including the most recent closing of its merger with Accovion, a European full-service CRO headquartered in Frankfurt (Eschborn), Germany.
Williams said, “Clinipace was built on the fundamental belief of improving clinical trial operations in terms of quality and cost, and we’re proud to say this is the foundation upon which Clinipace has grown to nearly 1,000 employees.”
Now in its 29th year, the Entrepreneur Of The Year Program has expanded globally to recognize company builders in over 145 cities and in more than 60 countries throughout the world.
The business leaders were selected by a panel of independent judges. Regional award recipients go on to compete at the national level. Award recipients in several national categories, as well as the National EY Entrepreneur Of The Year Overall Award winner, will be announced at the annual awards gala in Palm Springs, Calif. The awards are the culminating event of the EY Strategic Growth Forum, the nation’s most prestigious gathering of high-growth, market-leading companies.
To view the full article, please click here.